Ambu Awarded National Single-Use Endoscopy Contract with Premier Inc.

August 28, 2020:  Today Ambu Inc., announced today that it has been awarded a single-use endoscopy contract in the category of Surgical Disposable Scopes with Premier Inc., one of the largest performance improvement alliances of hospitals and healthcare systems in the U.S. In addition, Ambu was the only supplier of single-use endoscopes designated to participate in Premier’s SURPASS and ASCEND purchasing programs.

The three-year agreement creates a single-use endoscopy category specifically for the Premier membership and was signed this week, effective November 1, 2020. The partnership with Premier – whose members represent 4,100 hospital and health systems in the U.S. and 200,000 other providers – will further accelerate Ambu’s rapidly expanding share of the single-use endoscope market by giving those accounts pre-negotiated pricing and terms for Ambu’s full suite of endoscopy products.

Premier’s SURPASSTM program represents $8.4 billion in annual supply chain purchasing, with more than 30,000 acute care beds across 24 states and two U.S. territories. The ASCEND group purchasing program, meanwhile, is one of the nation’s largest committed purchasing programs with more than 120,000 acute care beds and a combined purchasing volume of more than $18 billion.

Boosting Ambu’s market share

Ninety-six percent of the top 500 bronchoscopy accounts in the U.S. are already using Ambu’s sterile, single-use bronchoscopes in the OR and ICU. Over the past twelve months, Ambu has increased its market share in these accounts and across all US hospitals, as the market continues to transition to single-use bronchoscopy.
This partnership with Premier will further boost Ambu’s market share by giving more accounts access to its full suite of single-use endoscopy products.

“The agreement allows Ambu to tap into a vast market of hospitals, health systems and healthcare providers across the U.S. with our single-use endoscopes,” said Juan Jose Gonzalez, CEO of Ambu A/S. “It strengthens our position in the U.S. and demonstrates the value of our portfolio in improving workflows and increasing patient safety. Premier is an exceptional company that we have known for years and we look forward to continue building our relationship with a company that is transforming the healthcare industry.”

Premier is highly regarded for its work driving efficiencies in hospitals and healthcare systems. Over the years, it has developed an alliance of more than 4,100 U.S. hospitals and health systems and over 200,000 other providers and organizations.

Ambu launched the world’s first single-use flexible bronchoscope, the Ambu® aScopeTM in 2009. In 2019, over 600,000 Ambu single-use endoscopes were used in more than 6,000 hospitals making Ambu the world’s largest supplier of single-use endoscopes. In 2020, Ambu expects to sell over 1 million single-use endoscopes.

Ambu received 510(k) clearance from the U.S. Food and Drug Administration in July 2020 for its single-use aScopeTM Duodeno, and the FDA cleared Ambu’s aScopeTM 4 Cysto in April 2020. By 2022, Ambu plans to introduce another 12 new devices across all major areas of endoscopy, including GI, the largest endoscopy market globally.

SourceAmbu
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version